Progesterone Receptor Modulators Induce Apoptosis in Mammary Tumors and Uterine Leiomyomas
book-chapter
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (82)
- Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy via openalex
- CDB-4124, a Progesterone Receptor Modulator, Inhibits Mammary Carcinogenesis by Suppressing Cell Proliferation and Inducing Apoptosis via openalex
- Chronic Antiprogestin Therapy Produces a Stable Atrophic Endometrium With Decreased Fibroblast Growth Factor: A 1-Year Primate Study on Contraception and Amenorrhea via openalex
- Clinical utility of progesterone receptor modulators and their effect on the endometrium via openalex
- Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis via openalex
- Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator via openalex
- Endometriosis: Current Management and Future Trends via openalex
- Endometriosis: Current Management and Future Trends via openalex
- Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: effects of progesterone receptor antagonists via openalex
- Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications via openalex
- W1991259200 via openalex
- W1995479702 via openalex
- W1998086840 via openalex
- W2016434268 via openalex
- W2016765391 via openalex
- W2017958278 via openalex
- W2026143081 via openalex
- W2026392453 via openalex
- W2026731274 via openalex
- W2034290334 via openalex
- W2045180596 via openalex
- W2047778962 via openalex
- W2048957217 via openalex
- W2051167148 via openalex
- W2053508270 via openalex
- W2063169494 via openalex
- W2063290052 via openalex
- W2063874882 via openalex
- W2064209182 via openalex
- W2066716403 via openalex
- W2066740282 via openalex
- W2067176980 via openalex
- W2069081394 via openalex
- W2078511129 via openalex
- W2085419794 via openalex
- W2090603595 via openalex
- W2099737493 via openalex
- W2103143130 via openalex
- W2104924788 via openalex
- W2108790636 via openalex
- W2120423870 via openalex
- W2122408366 via openalex
- W2124483957 via openalex
- W2124742378 via openalex
- W2129353515 via openalex
- W2132641866 via openalex
- W2142358927 via openalex
- W2146080966 via openalex
- W2146184294 via openalex
- W2146904742 via openalex
- W2148466832 via openalex
- W2148618596 via openalex
- W2153293697 via openalex
- W2154991551 via openalex
- W2157335501 via openalex
- W2160281835 via openalex
- W2162798777 via openalex
- W2165360990 via openalex
- W2165639852 via openalex
- W2240026114 via openalex
- W2246590518 via openalex
- W2327606978 via openalex
- W2402502269 via openalex
- W2408701001 via openalex
- W2412125288 via openalex
- W2413072934 via openalex
- W2515721699 via openalex
- W2587790761 via openalex
- W4241779753 via openalex
- W4246691084 via openalex
- W4250216416 via openalex
- W101268677 via openalex
- W4319720718 via openalex
- W617029850 via openalex
- W1586699954 via openalex
- W1593442063 via openalex
- W1611983322 via openalex
- W1809749161 via openalex
- W1838292546 via openalex
- W1975323045 via openalex
- W1976226412 via openalex
- W1984901643 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK